Bayer study 15791 - Mechanism of action (MoA) study 3month oral dosing of Vilaprisan or Ulipristal in patients with uterine fibroids scheduled for hysterectomy

Dataset

Description

Essential source documentation for the study.
Date made available2021
PublisherEdinburgh DataVault
Geographical coverageLothian

Cite this